Top-line forecast

Sarepta Therapeutics (SRPT) is expected to report its third quarter of fiscal 2018 earnings on October 24. Analysts expect revenues to increase 72.27% to $79.17 million, from $45.95 million in the third quarter of fiscal 2017.

Sarepta Therapeutics’ Q3 2018 Earnings: What Can We Expect?

For fiscal 2018 and fiscal 2019, Sarepta Therapeutics is expected to generate revenues of $302.12 million and $429.78 million, respectively. In fiscal 2017, its revenues were $154.58 million. Its gross margin is expected to contract from 93.3% in the third quarter of fiscal 2017 to 84.55% in the third quarter of fiscal 2018.

Operational performance

Sarepta Therapeutics is expected to incur selling, general, and administrative expenses of $47.7 million in the third quarter of 2018 compared to $62.41 million in the third quarter of 2017, a decrease of 23.57%.

Its research and development expenses, on the other hand, are expected to increase to $68.83 million from $34.24 million in Q3 2017.

Bottom line

Sarepta Therapeutics is expected to incur a net loss of $50.95 million in the third quarter of 2018. Its net loss was $47.73 million in the same quarter last year. That translates to a net loss per share of $0.74 compared to a net loss per share of $0.78 in the third quarter of fiscal 2017.

Latest articles

HEXO reported its third-quarter earnings on June 12. The company reported revenues of $13.0 million, which fell short of analysts’ estimate.

The Hot Chips 31 Symposium started this week. Artificial intelligence was the hot topic among participants Intel, NVIDIA, and Advanced Micro Devices.

Today, Slack (WORK) opened 4.5% higher after MKM Partners analyst Rohit Kulkarni gave Slack stock a "buy" rating with a target price of $40.

Today, Aphria announced a deal with ParcelPal to deliver medical cannabis to patients. Also, Cole Cacciavillani's son has won a cannabis store license.

Today, IHS Markit released the US manufacturing PMI (purchasing managers’ index) data for August. The manufacturing PMI hit 49.9, down from 50.4 in July.

On May 1, smokable hemp will be banned in North Carolina. The state passed the North Carolina Farm Act, removing smokable hemp from its permissible list.